COSMOS Pharmaceutical Corporation (CSMYF)
USD 46.06
(-0.22%)
USD 46.06
(-0.22%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 188.3 Billion JPY | 11.61% |
| 2023 | 168.71 Billion JPY | 11.4% |
| 2022 | 151.44 Billion JPY | 4.37% |
| 2021 | 145.11 Billion JPY | 7.5% |
| 2020 | 134.98 Billion JPY | 10.84% |
| 2019 | 121.78 Billion JPY | 10.39% |
| 2018 | 110.31 Billion JPY | 10.27% |
| 2017 | 100.04 Billion JPY | 15.19% |
| 2016 | 86.85 Billion JPY | 11.24% |
| 2015 | 78.07 Billion JPY | 10.66% |
| 2014 | 70.55 Billion JPY | 14.2% |
| 2013 | 61.78 Billion JPY | 16.61% |
| 2012 | 52.98 Billion JPY | 16.45% |
| 2011 | 45.5 Billion JPY | 13.57% |
| 2010 | 40.06 Billion JPY | 11.24% |
| 2009 | 36.01 Billion JPY | 10.15% |
| 2008 | 32.69 Billion JPY | 15.31% |
| 2007 | 28.35 Billion JPY | 21.77% |
| 2006 | 23.28 Billion JPY | 31.45% |
| 2005 | 17.71 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | 188.3 Billion JPY | 11.61% |
| 2024 Q4 | 48.64 Billion JPY | 4.09% |
| 2024 Q3 | 46.73 Billion JPY | 1.77% |
| 2024 Q1 | 47.01 Billion JPY | 5.86% |
| 2024 Q2 | 45.91 Billion JPY | -2.33% |
| 2023 FY | 168.71 Billion JPY | 11.4% |
| 2023 Q2 | 40.92 Billion JPY | -3.25% |
| 2023 Q3 | 41.09 Billion JPY | 0.43% |
| 2023 Q4 | 44.4 Billion JPY | 8.06% |
| 2023 Q1 | 42.29 Billion JPY | 5.75% |
| 2022 Q3 | 37.25 Billion JPY | 2.91% |
| 2022 FY | 151.44 Billion JPY | 4.37% |
| 2022 Q4 | 39.99 Billion JPY | 7.34% |
| 2022 Q2 | 36.2 Billion JPY | -4.7% |
| 2022 Q1 | 37.98 Billion JPY | 4.7% |
| 2021 Q1 | 38.23 Billion JPY | 4.03% |
| 2021 Q2 | 35.38 Billion JPY | -7.46% |
| 2021 Q4 | 36.28 Billion JPY | 3.06% |
| 2021 Q3 | 35.2 Billion JPY | -0.51% |
| 2021 FY | 145.11 Billion JPY | 7.5% |
| 2020 Q1 | 33.04 Billion JPY | 3.4% |
| 2020 Q4 | 36.75 Billion JPY | 9.27% |
| 2020 FY | 134.98 Billion JPY | 10.84% |
| 2020 Q3 | 33.64 Billion JPY | 6.66% |
| 2020 Q2 | 31.53 Billion JPY | -4.56% |
| 2019 FY | 121.78 Billion JPY | 10.39% |
| 2019 Q3 | 29.84 Billion JPY | 1.81% |
| 2019 Q4 | 31.95 Billion JPY | 7.07% |
| 2019 Q1 | 30.66 Billion JPY | 3.84% |
| 2019 Q2 | 29.31 Billion JPY | -4.38% |
| 2018 Q2 | 25.83 Billion JPY | -6.75% |
| 2018 FY | 110.31 Billion JPY | 10.27% |
| 2018 Q4 | 29.52 Billion JPY | 8.31% |
| 2018 Q3 | 27.25 Billion JPY | 5.52% |
| 2018 Q1 | 27.7 Billion JPY | 8.17% |
| 2017 Q1 | 25.44 Billion JPY | 9.53% |
| 2017 Q4 | 25.6 Billion JPY | 3.45% |
| 2017 FY | 100.04 Billion JPY | 15.19% |
| 2017 Q2 | 24.23 Billion JPY | -4.74% |
| 2017 Q3 | 24.75 Billion JPY | 2.13% |
| 2016 Q2 | 20.93 Billion JPY | -2.36% |
| 2016 FY | 86.85 Billion JPY | 11.24% |
| 2016 Q3 | 21.23 Billion JPY | 1.43% |
| 2016 Q1 | 21.44 Billion JPY | 2.69% |
| 2016 Q4 | 23.23 Billion JPY | 9.37% |
| 2015 FY | 78.07 Billion JPY | 10.66% |
| 2015 Q1 | 19.07 Billion JPY | 7.85% |
| 2015 Q2 | 19.18 Billion JPY | 0.58% |
| 2015 Q3 | 18.93 Billion JPY | -1.29% |
| 2015 Q4 | 20.88 Billion JPY | 10.29% |
| 2014 Q1 | 18.24 Billion JPY | 10.34% |
| 2014 FY | 70.55 Billion JPY | 14.2% |
| 2014 Q4 | 17.68 Billion JPY | 3.35% |
| 2014 Q3 | 17.11 Billion JPY | -2.33% |
| 2014 Q2 | 17.51 Billion JPY | -3.98% |
| 2013 Q4 | 16.53 Billion JPY | 11.47% |
| 2013 FY | 61.78 Billion JPY | 16.61% |
| 2013 Q1 | 15.7 Billion JPY | 11.04% |
| 2013 Q2 | 14.71 Billion JPY | -6.27% |
| 2013 Q3 | 14.83 Billion JPY | 0.79% |
| 2012 Q1 | 13.29 Billion JPY | 7.85% |
| 2012 FY | 52.98 Billion JPY | 16.45% |
| 2012 Q3 | 12.91 Billion JPY | 2.25% |
| 2012 Q2 | 12.63 Billion JPY | -4.96% |
| 2012 Q4 | 14.14 Billion JPY | 9.46% |
| 2011 FY | 45.5 Billion JPY | 13.57% |
| 2011 Q4 | 12.32 Billion JPY | 12.51% |
| 2011 Q1 | 11.51 Billion JPY | 8.17% |
| 2011 Q2 | 10.7 Billion JPY | -7.03% |
| 2011 Q3 | 10.95 Billion JPY | 2.33% |
| 2010 Q2 | 10.19 Billion JPY | -1.92% |
| 2010 Q1 | 10.39 Billion JPY | 6.07% |
| 2010 Q4 | 10.64 Billion JPY | 13.78% |
| 2010 FY | 40.06 Billion JPY | 11.24% |
| 2010 Q3 | 9.35 Billion JPY | -8.26% |
| 2009 Q2 | 8.63 Billion JPY | 0.0% |
| 2009 Q4 | 9.8 Billion JPY | 10.92% |
| 2009 FY | 36.01 Billion JPY | 10.15% |
| 2009 Q3 | 8.83 Billion JPY | 2.37% |
| 2008 FY | 32.69 Billion JPY | 15.31% |
| 2007 FY | 28.35 Billion JPY | 21.77% |
| 2006 FY | 23.28 Billion JPY | 31.45% |
| 2005 FY | 17.71 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 134.07 Million USD | -140344.568% |
| Café Serendipity Holdings, Inc. | 1196.00 USD | -15744648729.431% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | - USD | -Infinity% |
| HealthWarehouse.com, Inc. | 12.17 Million USD | -1546698.783% |
| LIGAND PHARMACEUTICAL INC | 88.02 Million USD | -213820.887% |
| MedGen, Inc. | 1.05 USD | -17933904761804.762% |
| Omni Health, Inc. | 1.55 Million USD | -12128775.013% |
| Oxford Investments Holdings Inc. | 31.45 Thousand USD | -598594851.999% |
| Pineapple, Inc. | -1.02 Million USD | 18376939.089% |
| ScripsAmerica, Inc. | 27.59 Million USD | -682240.083% |